Status:
UNKNOWN
The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Phosphate Deficiency
Covid19
Eligibility:
All Genders
Brief Summary
The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.
Eligibility Criteria
Inclusion
- Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study
Exclusion
- there is no exclusion criteria
Key Trial Info
Start Date :
March 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04800770
Start Date
March 3 2021
End Date
July 31 2021
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital
Ankara, Turkey (Türkiye), 06800